High flow nasal cannula in adults with acute respiratory failure

Guidelines session
Chairs: A. Simonds (London, United Kingdom), W. Randerath (Solingen, Germany)
Aims: To provide the evidence on the application of high flow nasal cannula (HFNC) in adults with acute respiratory failure in different clinical scenarios, concerning a critical and patient centered outcomes (ie. mortality, intubation, lung gas exchange, comfort, dyspnea).

Physiologic rationale and clinical pitfalls R. Scala (Arezzo, Italy)
Non-invasive respiratory treatment options and recommendations S. Oczkowski (Hamilton, ON, Canada)
Practical approach with cases, interactive questions and discussion B. Ergan (Izmir, Turkey)